Latest Breaking News On - Promisingpreclinicalstudiessupport first - Page 1 : comparemela.com

Camsirubicin Phase 1b Trial Currently at 5th Dose­-Level , Generating Encouraging ResultsMNPR-101 Radiopharma Program Advancing Toward First-in-Human Studies WILMETTE, Ill., Aug. 10, 2023 . -Today at 07:03 am- MarketScreener

Anand jeyasekharanKimr tsuchimotoPromisingpreclinicaldataignitefurther researchRadiopharma program advancing towardNorthstar medical radioisotopesCancer science instituteMonopar therapeutics incCompany nasdaqNational university of singaporeExchange commissionTrial currentlyGenerating encouragingProgram advancing toward first in humanPromisingpreclinicalstudiessupport firstNational universitySecondquarterended june